- £88.27m
- £99.46m
- £32.97m
- 66
- 58
- 63
- 70
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 18.8 | 21.1 | 17.3 | 49.1 | 33 |
Cost of Revenue | |||||
Gross Profit | 16.4 | 18.8 | 15.8 | 18.7 | 15.8 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 7.64 | 25.5 | 19.2 | 21.6 | 65 |
Operating Profit | 11.1 | -4.4 | -1.92 | 27.5 | -32 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 6.43 | -9.07 | -5.53 | 24.6 | -35.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | 5.17 | -5.44 | -5.53 | 24.5 | -35.7 |
Net Income Before Extraordinary Items | |||||
Net Income | 5.17 | -5.44 | -5.53 | 24.5 | -35.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 5.17 | -5.44 | -5.53 | 24.5 | -35.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.128 | -0.097 | -0.129 | 0.532 | -0.802 |
Dividends per Share |